Cargando…

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2016
Materias:	Corrections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067088/ https://www.ncbi.nlm.nih.gov/pubmed/27754841 http://dx.doi.org/10.1136/bmj.i5602

Ejemplares similares

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
por: Puymirat, Etienne, et al.
Publicado: (2016)

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
por: Dondo, Tatendashe B., et al.
Publicado: (2017)

Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
por: Desta, Liyew, et al.
Publicado: (2020)

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015)

The duration of beta‐blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study
por: Wen, Xue‐Song, et al.
Publicado: (2022)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Publicado: (2013)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Correction: An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors
Publicado: (2018)

Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study
por: Wen, Xue-song, et al.
Publicado: (2022)

Long‐term impact of β‐blocker in elderly patients without myocardial infarction after percutaneous coronary intervention
por: Fukase, Tatsuya, et al.
Publicado: (2021)

Correction: Underweight, Markers of Cachexia, and Mortality in Acute Myocardial Infarction: A Prospective Cohort Study of Elderly Medicare Beneficiaries
Publicado: (2016)

Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records
por: Quint, J K, et al.
Publicado: (2013)

β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
por: Andell, Pontus, et al.
Publicado: (2015)

Effect of β‐Blockers Beyond 3 Years After Acute Myocardial Infarction
por: Park, Jin Joo, et al.
Publicado: (2018)

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure
Publicado: (2019)

Comparison Between Fimasartan Versus Other Angiotensin Receptor Blockers in Patients With Heart Failure After Acute Myocardial Infarction
por: Kim, Jihoon, et al.
Publicado: (2023)

Mechanism of heart failure after myocardial infarction
por: Jiang, Huaiyu, et al.
Publicado: (2023)

High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study
Publicado: (2015)

High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study
Publicado: (2016)

Due caution using early β-blockers for acute myocardial infarction
por: McKee, Scott, et al.
Publicado: (2007)

Correction: Comparison of 2‑year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry
por: Won, Ki‑Bum, et al.
Publicado: (2023)

β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study
por: Hagsund, Tora, et al.
Publicado: (2020)

β‐Blocker Therapy After Myocardial Infarction: A Little Goes a Long Way
por: Abbott, J. Dawn, et al.
Publicado: (2023)

Heart failure after myocardial infarction: incidence and predictors
por: Jenča, Dominik, et al.
Publicado: (2020)

Heart Failure After Right Ventricular Myocardial Infarction
por: Nägele, Matthias P., et al.
Publicado: (2022)

Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure
por: Chen, Yan, et al.
Publicado: (2020)

Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study
Publicado: (2018)

Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study
por: Chung, Jaehoon, et al.
Publicado: (2017)

Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry
por: Chung, Jaehoon, et al.
Publicado: (2021)

Association between lactate/albumin ratio and mortality in patients with heart failure after myocardial infarction
por: Chen, Yang, et al.
Publicado: (2023)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Effect of β-Blockers on the Risk of Atrial Fibrillation in Patients with Acute Myocardial Infarction
por: Pesaro, Antonio Eduardo, et al.
Publicado: (2010)

Health Literacy and Mortality: A Cohort Study of Patients Hospitalized for Acute Heart Failure
Publicado: (2015)

Correction: Impact of nutritional status on heart failure mortality: a retrospective cohort study
por: Carime, Nafz Abdoul, et al.
Publicado: (2022)

Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes
por: Ritsinger, Viveca, et al.
Publicado: (2021)

Myocardial Longitudinal Strain in Prediction of Heart Failure after Acute Myocardial Infarction
por: Chung, Hyemoon
Publicado: (2019)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction
por: Del Buono, Marco Giuseppe, et al.
Publicado: (2022)

β‐Blockers and 1‐Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate
por: Park, Jin Joo, et al.
Publicado: (2019)

Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure
por: Wahid, Abdul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j8td15ofrmjqg37pr8oooi36d6